exRNA Therapeutics
PrivateLast Round
Accelerator
Jun 3, 2022
Company Overview
exRNA Therapeutics is a biotechnology company that specializes in the research and development of RNA-based therapeutics, including antisense oligonucleotide therapies and RNA interference solutions, to address rare, neurological, and autoimmune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
exRNA Therapeutics Comparables
Compare exRNA Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Tevard Biosciences | 76% | |
| HAYA Therapeutics | 72% | |
| Alltrna | 70% |
exRNA Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Jun 3, 2022 |
exRNA Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ASPIRE-BioNEST | Accelerator |
exRNA Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about exRNA Therapeutics's valuation, stock price, and market status.
Is exRNA Therapeutics a public or private company?
exRNA Therapeutics is a private company.
What is the current stock price of exRNA Therapeutics?
exRNA Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is exRNA Therapeutics worth (valuation)?
Valuation information for exRNA Therapeutics is not publicly available.
Can I buy exRNA Therapeutics stock?
exRNA Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was exRNA Therapeutics's last funding round?
exRNA Therapeutics's most recent funding round was Accelerator on June 3, 2022.
Who are the main investors in exRNA Therapeutics?
Key investors in exRNA Therapeutics include ASPIRE-BioNEST.
Will exRNA Therapeutics IPO soon?
No public IPO plans have been announced for exRNA Therapeutics.
How can I track exRNA Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor exRNA Therapeutics's secondary market activity and sign up for updates.